| 000 | 01376 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250511202637.0 | ||
| 264 | 0 | _c19920324 | |
| 008 | 199203s 0 0 eng d | ||
| 022 | _a0007-0920 | ||
| 024 | 7 |
_a10.1038/bjc.1992.38 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNordenberg, J | |
| 245 | 0 | 0 |
_aNovobiocin-induced anti-proliferative and differentiating effects in melanoma B16. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cFeb 1992 |
||
| 300 |
_a183-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCell Count _xdrug effects |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 |
_aMelanoma, Experimental _xpathology |
| 650 | 0 | 4 |
_aMycophenolic Acid _xpharmacology |
| 650 | 0 | 4 |
_aNovobiocin _xpharmacology |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aRibavirin _xanalogs & derivatives |
| 700 | 1 | _aAlbukrek, D | |
| 700 | 1 | _aHadar, T | |
| 700 | 1 | _aFux, A | |
| 700 | 1 | _aWasserman, L | |
| 700 | 1 | _aNovogrodsky, A | |
| 700 | 1 | _aSidi, Y | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 65 _gno. 2 _gp. 183-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bjc.1992.38 _zAvailable from publisher's website |
| 999 |
_c1746011 _d1746011 |
||